![Thomas Malley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Malley
Direktor/Vorstandsmitglied bei
KURA ONCOLOGY, INC.
Vermögen: 7 Mio $ am 30.06.2026
Profil
Thomas R.
Malley is currently Chairman at Project C.U.R.E., Inc., Independent Director at Kura Oncology, Inc. since 2015, Director at Benevolent Healthcare Foundation, Independent Director at Kiniksa Pharmaceuticals Ltd. and Kiniksa Pharmaceuticals Corp.
since 2016, Independent Director at Kiniksa Pharmaceuticals International Plc since 2024, and President at Mossrock Capital LLC since 2007.
Former positions include Director at Cougar Biotechnology, Inc. from 2007 to 2009, Director at Innovative Acquisitions Corp., Board of Director at Craig Hospital from 2007 to 2013, Director at Janssen Oncology, Inc. from 2007 to 2009, Independent Director at Puma Biotechnology, Inc. from 2011 to 2015, Independent Director at OvaScience, Inc. from 2012 to 2017, Independent Director at Synageva BioPharma Corp.
from 2012 to 2015, Independent Non-Executive Director at BeOne Medicines Ltd. from 2016 to 2024, Executive Vice President at Janus Henderson Investors US LLC from 1991 to 2008, and Portfolio Manager at Janus Henderson Global Life Sciences Fund from 1999 to 2007.
Education includes an undergraduate degree from Stanford University conferred in 1991.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
0,19 % | 29.05.2026 | 87.312 ( 0,19 % ) | 6 Mio $ | 30.06.2026 |
KURA ONCOLOGY, INC. 0,17 % | 04.06.2026 | 149.557 ( 0,17 % ) | 2 Mio $ | 30.06.2026 |
Aktive Positionen von Thomas Malley
| Unternehmen | Position | Beginn |
|---|---|---|
| KURA ONCOLOGY, INC. | Direktor/Vorstandsmitglied | 14.10.2015 |
Project C.U.R.E., Inc.
 Project C.U.R.E., Inc. Medical/Nursing ServicesHealth Services Provides substance abuse treatment and drug rehabilitation programs services | Vorsitzender | - |
Mossrock Capital LLC
 Mossrock Capital LLC Investment ManagersFinance Mossrock Capital invests in middle market companies located in the United States. The firm has been investing in both public and private equity in healthcare sector. It also provides financing for early stage capital requirements. | Präsident | 01.05.2007 |
Kiniksa Pharmaceuticals Ltd.
 Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Direktor/Vorstandsmitglied | 01.12.2016 |
Kiniksa Pharmaceuticals Corp.
 Kiniksa Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops and commercializes therapeutic medicines for patients suffering from debilitating diseases | Direktor/Vorstandsmitglied | 01.12.2016 |
Benevolent Healthcare Foundation
 Benevolent Healthcare Foundation Medical/Nursing ServicesHealth Services Provides medical supplies and services | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Thomas Malley
| Unternehmen | Position | Ende |
|---|---|---|
| BEIGENE LTD | Direktor/Vorstandsmitglied | 22.01.2024 |
OvaScience, Inc.
 OvaScience, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of new fertility treatment options for women | Direktor/Vorstandsmitglied | 12.06.2017 |
| SYNAGEVA BIOPHARMA CORP | Direktor/Vorstandsmitglied | 22.06.2015 |
| ░░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Thomas Malley
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
75
Beziehungen ersten Grades
17
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 17 |
|---|---|
Janus Henderson Investors US LLC
 Janus Henderson Investors US LLC Investment ManagersFinance JHIUS offers US equity, global and international equity, fixed income, asset allocation and alternative investment strategies, including long-short portfolios. For their fundamental investment strategies, the firm seeks to add value versus benchmarks by actively pursuing alpha generation through their own intensive fundamental research. They utilize two complementary processes: a top-down macro analysis and a bottom-up risk/reward analysis. | Finance |
Cougar Biotechnology, Inc. /Old/
 Cougar Biotechnology, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer | Health Technology |
Innovative Acquisitions Corp.
 Innovative Acquisitions Corp. Financial ConglomeratesFinance Provides investment services | Finance |
Kura Oncology, Inc.
 Kura Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Janus Henderson Global Life Sciences Fund
 Janus Henderson Global Life Sciences Fund Investment Trusts/Mutual FundsMiscellaneous Acts as Open-End Investment Fund/Unit Trust | Miscellaneous |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Craig Hospital
 Craig Hospital Hospital/Nursing ManagementHealth Services Provides rehabilitation services for people with spinal cord injury and traumatic brain injury | Health Services |
Benevolent Healthcare Foundation
Benevolent Healthcare Foundation Medical/Nursing ServicesHealth Services Provides medical supplies and services | Health Services |
Janssen Oncology, Inc.
 Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer | Health Technology |
Puma Biotechnology, Inc.
 Puma Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a development stage company which develops biopharmaceuticals used for the treatment of cancer | Health Technology |
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of new fertility treatment options for women | Health Technology |
Synageva BioPharma Corp.
 Synageva BioPharma Corp. BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Mossrock Capital LLC
Mossrock Capital LLC Investment ManagersFinance Mossrock Capital invests in middle market companies located in the United States. The firm has been investing in both public and private equity in healthcare sector. It also provides financing for early stage capital requirements. | Finance |
BeiGene Ltd.
 BeiGene Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Health Technology |
Project C.U.R.E., Inc.
Project C.U.R.E., Inc. Medical/Nursing ServicesHealth Services Provides substance abuse treatment and drug rehabilitation programs services | Health Services |
Kiniksa Pharmaceuticals Corp.
Kiniksa Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops and commercializes therapeutic medicines for patients suffering from debilitating diseases | Health Technology |
